Plus Therapeutics Presents Exciting New Clinical Data At Top Cancer Conference
- 9 months ago
Plus Therapeutics is a clinical-stage pharmaceutical company developing targeted radiotherapeutics with the potential to enhance clinical outcomes in patients with difficult-to-treat cancers of the central nervous system. The company’s technology allows for extremely precise radiotherapeutics.
The company recently presented data at the Society for Neuro-Oncology Conference in San Francisco. Early results from ongoing studies of the company’s lead drug candidate showed extremely promising responses from patients in phase 1.
The company recently presented data at the Society for Neuro-Oncology Conference in San Francisco. Early results from ongoing studies of the company’s lead drug candidate showed extremely promising responses from patients in phase 1.